Carla Letícia Bandeira

Carla Letícia Bandeira

Auto-generated profile, based on publicly available information

Carla Letícia Bandeira

Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in Placenta
Verified
Journal Article
Closed access
LPL. Pietro
L. Pietro
SDS. Daher
S. Daher
MRMarilza Vieira Cunha Rudge
Marilza Vieira Cunha Rudge
ICIracema Calderon
Iracema Calderon
DDDébora C Damasceno
Débora C Damasceno
EBEstela Bevilacqua
Estela Bevilacqua

6 March 2020 in Science Advances
Verified
Journal Article
Open access
ARAramys Silva Reis
Aramys Silva Reis
RBRenato Barboza
Renato Barboza
OMOscar Murillo
Oscar Murillo
ABAndré Barateiro
André Barateiro
EPErika P. M. Peixoto
Erika P. M. Peixoto
Claudio Romero Farias MarinhoClaudio Romero Farias Marinho
Claudio Romero Farias Marinho
IL-1 axis activation during placental malaria induces poor pregnancy outcomes that are obliterated after treatment with Anakinra.

17 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RBRenato Barboza
Renato Barboza
FLAVIA AFONSO LIMAFLAVIA AFONSO LIMA
FLAVIA AFONSO LIMA
ARAramys Silva Reis
Aramys Silva Reis
OMOscar Javier Murillo
Oscar Javier Murillo
EPErika Paula Machado Peixoto
Erika Paula Machado Peixoto
Claudio Romero Farias MarinhoClaudio Romero Farias Marinho
Claudio Romero Farias Marinho
Malaria-associate pregnancy has a significant impact on infant morbidity and mortality. The detrimental effects of malaria infection during pregnancy have been shown to correlate with immune activation in the placental tissue. Herein we sought to evaluate the effect of Toll-like receptors (TLRs) activation on placental malaria (PM) development by using the Plasmodium berghei NK65GFP infection model. We observed that activation of the innate immune system by parasites leads to PM due to local inflammation. We identified TLR4 activation as the main pathway involved in the inflammatory process in the placental tissue since the absence of functional TLR4 in mice leads to a decrease in the pro-inflammatory responses, which resulted in an improved pregnancy outcome. Additionally, a similar result was obtained when infected pregnant mice were treated with IAXO-101, a TLR4/CD14 blocker. Together, this study illustrates the importance of TLR4 signalling for the generation of the severe inflammatory response involved in PM pathogenesis. Therefore, our results implicate that TLR4 blockage could be a potential candidate for therapeutic interventions to reduce malaria-induced pathology both in the mother and the fetus.

1 August 2017 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
MRM.E. Ridano
M.E. Ridano
ARA.C. Racca
A.C. Racca
JFJ.B. Flores-Martin
J.B. Flores-Martin
RFR. Fretes
R. Fretes
CBC.L. Bandeira
C.L. Bandeira
GPG.M. Panzetta-Dutari
G.M. Panzetta-Dutari

23 February 2017 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
JXJose Xavier-Neto
Jose Xavier-Neto
MCMurilo Carvalho
Murilo Carvalho
BPBruno dos Santos Pascoalino
Bruno dos Santos Pascoalino
ACAlisson Campos Cardoso
Alisson Campos Cardoso
ÂCÂngela Maria Sousa Costa
Ângela Maria Sousa Costa
KFKleber Franchini
Kleber Franchini
The teratogenic mechanisms triggered by ZIKV are still obscure due to the lack of a suitable animal model. Here we present a mouse model of developmental disruption induced by ZIKV hematogenic infection. The model utilizes immunocompetent animals from wild-type FVB/NJ and C57BL/6J strains, providing a better analogy to the human condition than approaches involving immunodeficient, genetically modified animals, or direct ZIKV injection into the brain. When injected via the jugular vein into the blood of pregnant females harboring conceptuses from early gastrulation to organogenesis stages, akin to the human second and fifth week of pregnancy, ZIKV infects maternal tissues, placentas and embryos/fetuses. Early exposure to ZIKV at developmental day 5 (second week in humans) produced complex manifestations of anterior and posterior dysraphia and hydrocephalus, as well as severe malformations and delayed development in 10.5 days post-coitum (dpc) embryos. Exposure to the virus at 7.5–9.5 dpc induces intra-amniotic hemorrhage, widespread edema, and vascular rarefaction, often prominent in the cephalic region. At these stages, most affected embryos/fetuses displayed gross malformations and/or intrauterine growth restriction (IUGR), rather than isolated microcephaly. Disrupted conceptuses failed to achieve normal developmental landmarks and died in utero. Importantly, this is the only model so far to display dysraphia and hydrocephalus, the harbinger of microcephaly in humans, as well as arthrogryposis, a set of abnormal joint postures observed in the human setting. Late exposure to ZIKV at 12.5 dpc failed to produce noticeable malformations. We have thus characterized a developmental window of opportunity for ZIKV-induced teratogenesis encompassing early gastrulation, neurulation and early organogenesis stages. This should not, however, be interpreted as evidence for any safe developmental windows for ZIKV exposure. Late developmental abnormalities correlated with damage to the placenta, particularly to the labyrinthine layer, suggesting that circulatory changes are integral to the altered phenotypes. Previously thought to produce a harmless bout of fever associated with skin rash and muscle, or joint pain, the Zika virus (ZIKV) is an important cause of morbidity/mortality to human embryos/fetuses. Different from other models, here we report data from wild-type immunocompetent mice, rather than transgenic animals with suppressed immune responses. We found that intravascular ZIKV produced infection of maternal tissues, placentas and conceptuses, but that embryos/fetuses were comparatively much more affected than pregnant females, which seemed to tolerate well the viral challenge with no signs of encephalopathy. Importantly, 10.5 days post-coitum (dpc) embryos exposed to ZIKV at embryonic day 5 (second week in humans) displayed dysraphia, which is a regional failure of neural tube closure, and hydrocephalus, which is a symptom recently shown to precede microcephaly in humans. Characteristic phenotypes in more developed embryos/fetuses included abnormal articular postures analogous to arthrogryposis, which are typical human congenital contractures, gross and generalized malformations and intra uterine growth restriction (IUGR), rather than isolated microcephaly. Some developmental abnormalities and IUGR correlated with placental damage, suggesting that loss of placental function may play an important role in the disease. We believe our model is an asset in the search for useful concepts and prospective therapies for ZIKV because it better reproduces the human condition.

3 May 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
JDJamille G. Dombrowski
Jamille G. Dombrowski
RMRodrigo Medeiros Martorano
Rodrigo Medeiros Martorano
FLAVIA AFONSO LIMAFLAVIA AFONSO LIMA
FLAVIA AFONSO LIMA
CBCarla Letícia Bandeira
Carla Letícia Bandeira
OMOscar Murillo
Oscar Murillo
Claudio Romero Farias MarinhoClaudio Romero Farias Marinho
Claudio Romero Farias Marinho
Having malaria during pregnancy, especially falciparum malaria, can be devastating and fulminant, leading to high mortality rates for both mother and fetus, with approximately 125 million pregnancies at risk of infection each year.1 Infected erythrocytes accumulate and sequester in the placental intervillous space, causing placental histopathologic changes that trigger an exacerbated inflammatory response that is highly detrimental.2 A heightened inflammatory response perturbs the maternal-fetal interface and impairs critical placental functions. Therefore, maternal malaria is associated with major complications among fetuses and newborns, including being the primary cause of low birth weight, intrauterine growth retardation, abortion, stillbirth, premature delivery, and fetal death in malaria-endemic countries.1 In addition, in utero exposure to malaria parasites has been associated with a decreased head circumference (HC) among fetuses and newborns, a proportional decrease in size as an outcome of the intrauterine growth retardation.3-6